The FDA has approved a “landmark” drug that could help people with early stages of Alzheimer’s stave off mental decline for months – but it comes with risks.
Alzheimer’s Brains but no Dementia
The central dogma that has ruled neuroscience since the early ’90s tells us toxic plaques of amyloid and tangles of tau kill neurons and cause Alzheimer’s. But what about the 30% of older adults who have brains loaded with enough amyloid or tau to meet the criteria for an Alzheimer’s diagnosis, but no outward symptoms of dementia? New research published yesterday in Science Translational Medicine points toward a key driver of such resilience: a family of proteins that act as a master regulator in the brain, preventing neurons from firing out of control.
Read more
Take Action!
Looking for guidance on strategies to increase the health of your community? Check out the County Health Rankings Guide! You will find a menu of evidence-informed policies and programs that can make a difference locally, step-by-step guidance and tools to help you move from data to action, and tips on how to identify the right partners and engage with them!
- Action Center – step-by-step guidance and tools
- What Works for Health – policies and programs
- Partner Center – identification of partners